Concepedia

Tiefu Xiong

TX

Statistics

Publications

7

Citations

330

H-Index

7

Active since

2017

Affiliations

Peking University Shenzhen Hospital(Current)

Anhui Medical University

University of Hong Kong - Shenzhen Hospital

Tiefu Xiong is an author at Peking University Shenzhen Hospital specializing in molecular oncology, oncology, and medicine.

Publications per year

2017–2020

7

Publications

7

N6‐methyladenosine demethylase <scp>FTO</scp> suppresses clear cell renal cell carcinoma through a novel <scp>FTO</scp>‐<scp>PGC</scp>‐1α signalling axis

Changshui Zhuang, Chengle Zhuang, Xiaomin Luo et al. · Journal of Cellular and Molecular Medicine · 2019 · 146 citations · Full text

, , +17

MiR-31-5p acts as a tumor suppressor in renal cell carcinoma by targeting cyclin-dependent kinase 1 (CDK1)

Yawen Li, Jing Quan, Fangfang Chen et al. · Biomedicine & Pharmacotherapy · 2018 · 48 citations · Full text

, , +17

A CRISPR Interference of CBP and p300 Selectively Induced Synthetic Lethality in Bladder Cancer Cells <i>In Vitro</i>

Jianfa Li, Chenchen Huang, Tiefu Xiong et al. · International Journal of Biological Sciences · 2019 · 37 citations · Full text

, , +14

The miR‐140‐5p/KLF9/KCNQ1 axis promotes the progression of renal cell carcinoma

Chenchen Huang, Jianfa Li, Xiaoting Zhang et al. · The FASEB Journal · 2020 · 32 citations · Full text

, , +17

lncRNA CASC9 sponges miR‑758‑3p to promote proliferation and EMT in bladder cancer by upregulating TGF‑β2

Zeng Zhang, Fangfang Chen, Hongrui Zhan et al. · Oncology Reports · 2020 · 29 citations · Full text

, , +17

1–5 of 7